Myeloma & Lymphoma - Part I
Tracks
Plenary Hall
| Saturday, September 5, 2026 |
| 9:00 AM - 10:55 AM |
Speaker
Dr. Robert Hasserjian
Hematopathologist, Massachusetts General Hospital
Professor of Pathology, Harvard Medical School
TBA
9:00 AM - 9:20 AM
Prof. Jesús San-Miguel
Professor of Medicine-Hematology, Director of Clinical and Translational Medicine
University of Navarra
Myeloma Therapy in 2026: Aiming for Cure
9:20 AM - 9:40 AM
Dr. Ranjana Advani
Saul A. Rosenberg Professor of Lymphoma
Stanford Cancer Institute
Frontline Therapy in Advanced Stage HL: Is ABVD Redundant?
9:40 AM - 10:00 AM
Prof. Jesús San-Miguel
Professor of Medicine-Hematology, Director of Clinical and Translational Medicine
University of Navarra
Relapsed Myeloma: Sequencing Therapy
10:00 AM - 10:20 AM
Dr. Jeremy Abramson
Director, Center for Lymphoma
Massachusetts General Hospital
How I Treat MCL in 2026
10:20 AM - 10:40 AMSession Chair
Zeyad Al Shaibani
Section Head Hematology and Blood and Bone Marrow Transplant
King Faisal Specialist Hospital
Inas El Najjar
Consultant, Hematology & Bone Marrow Transplant / Director Undergraduate & Advance Program
Abu Dhabi Stem Cell Center/Yas Clinic Khalifa City
Panayotis Kaloyannidis
Consultant Hematologist
Burjeel Medical City
Mahmoud Marashi
Vice President, Emirates Society of Haematology
Consultant Hematologist, Mediclinic City Hospital
